After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump's ...

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...

Learn more about whether Corcept Therapeutics Incorporated or GSK plc is a better investment based on AAII's A+ Investor ...

Large drugmakers have global manufacturing footprints, mainly in the U.S., Europe and Asia, and moving more production to the ...

Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...

In this role, Kulkarni will drive the agency’s strategic expansion, strengthen its market position, and spearhead its next ...

If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...

Drugmakers are lobbying President Trump to phase in tariffs on imported pharmaceutical products to alleviate the impact and ...

BioVersys highlighted the urgent need for safe treatments for CRAB infections, which can have death rates in hospitals as ...

Exclusive reporting on Munster, national and international business news and how it impacts Ireland and the poeple who live ...

Sanofi hires former GSK development head Chris Corsico as global R&D head, replacing Dietmar Berger who left for Gilead. Move ...